박인규 (전남대학교)님 | 한빛사연구자 > 한빛사

전남대학교

CV File

최종업데이트 2026.05.29.

ROS-responsive nanocarriers for the delivery of atorvastatin in ischemic MCAO rats promoting neuroprotection
- Mater. Today Bio, Available online 28 May 2026, 103296 | https://doi.org/10.1016/j.mtbio.2026.103296
- 2026-05
- 의약학
- 한빛사논문
Multiscale molecular modeling–directed ROS-responsive nanotherapy for dual-axis regulation of fibrotic and inflammatory signaling in alport nephropathy
- J. Nanobiotechnol., 12 May 2026 | https://doi.org/10.1186/s12951-026-04451-w
- 2026-05
- 의약학
- 한빛사논문
Carbohydrate polymer-based biomaterials for light-triggered Photo-Immunotherapy: Design strategies, immune mechanisms, and translational outlook
- Mater. Today Bio, Available online 1 April 2026 | https://doi.org/10.1016/j.mtbio.2026.103069
- 2026-04
- 바이오·의료융합
- 한빛사논문
Cuproptosis-Inducing Photothermal Nanotherapy Coupled with ECM Destabilization Drives Potent Tumor Regression and Immune Reawakening.
- Mater. Today Bio, Available online 2 March 2026, 103003 | https://doi.org/10.1016/j.mtbio.2026.103003
- 2026-03
- 바이오·의료융합
- 한빛사논문
Bioorthogonal Cu-MOF nanocatalyst enables GSH-triggered in situ drug synthesis for xCT-driven ferroptosis in colorectal cancer
- J. Control. Release, Available online 2 March 2026, 114775 | https://doi.org/10.1016/j.jconrel.2026.114775
- 2026-03
- 바이오·의료융합
- 한빛사논문
AI-guided design of a CXCR4-targeted core-shell nanocarrier for co-delivery of berberine/paclitaxel in cancer therapy
- J. Nanobiotechnol., Nov 22 2025, | https://doi.org/10.1186/s12951-025-03850-9
- 2025-11
- 바이오·의료융합
- 한빛사논문
A Dual-Modality nanozyme Exploiting ROS-Responsive oxygen Catalysis for Precision NF-κB pathway Suppression in gouty arthritis
- Chem. Eng. J., Available online 22 May 2025, 164064 | https://doi.org/10.1016/j.cej.2025.164064
- 2025-05
- 바이오·의료융합
- 한빛사논문
Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment
- J. Immunother. Cancer, Mar 21 2025, 13 (3) e010272 | https://doi.org/10.1136/jitc-2024-010272
- 2025-03
- 의약학
- 한빛사논문
Programable Prodrug Nanomodulator Targets Tumor Redox Homeostasis Imbalance to Amplify Disulfidptosis and Immunogenic Pyroptosis for Breast Tumor Immunotherapy
- Adv. Healthc. Mater., Mar 20 2025, | https://doi.org/10.1002/adhm.202500272
- 2025-03
- 바이오·의료융합
- 한빛사논문
Triple-action cancer therapy using laser-activated NO-releasing metallomicellar nanophotosensitizer for pyroptosis-driven immune reprogramming
- J. Control. Release, Jan 07 2025, S0168-3659(25)00013-6 | https://doi.org/10.1016/j.jconrel.2025.01.012
- 2025-01
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기